Just as nephrologists are adept at detecting and managing the hyperkalemia of renin-angiotensin-system (RAS) inhibitors, we will need to master the art of treating the gastrointestinal disorders that are found in over half the recipients of GLP-1s (Figure 9)
Biosynthetic pathways or anabolic pathways convert simple metabolites (e.g., sugars and amino acids) to complex molecules through ATP-dependent processes
Infertility affects roughly 30 to 50% of those diagnosed
Skin Conditioning Support Copper peptides have been studied for their cosmetic role in collagen support and skin renewal
During times of transition to hemodialysis or peritoneal dialysis, consideration must be given to insulin dosing adjustments for subjects with T1DM in efforts to maintain glycemic control
GLP-1 weight loss uses a class of medications that mimic GLP-1, a natural gut hormone that helps regulate appetite, blood sugar, and digestion